Covered recipient · General Payments record
MARK E BOSCHERT
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2019–2024
$1,187.86
- Reported across 67 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $163.55 | 9 |
| Education | $30.40 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Gilead Sciences, Inc. | $67.41 | 3 |
| Janssen Biotech, Inc. | $31.03 | 2 |
| PFIZER INC. | $30.40 | 1 |
| INTERCEPT PHARMACEUTICALS, INC. | $30.14 | 2 |
| Organon LLC | $20.94 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.03 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Gilead Sciences, Inc. | $20.27 | 03/14/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1133842771 | CMS |
| Gilead Sciences, Inc. | $22.06 | 04/25/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1133842773 | CMS |
| Gilead Sciences, Inc. | $25.08 | 06/07/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1133842775 | CMS |
| Intercept Pharmaceuticals, Inc. | $16.84 | 02/29/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1113638601 | CMS |
| Intercept Pharmaceuticals, Inc. | $13.30 | 04/08/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1113638606 | CMS |
| Janssen Biotech, Inc. | $15.95 | 02/06/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1078785734 | CMS |
| Janssen Biotech, Inc. | $15.08 | 05/07/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1078785918 | CMS |
| Organon Llc | $20.94 | 06/27/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1136253260 | CMS |
| PFIZER INC. | $30.40 | 04/09/2024 | Education | Undisputed | 06/30/2026 | 1228915864 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.03 | 05/02/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1137493555 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.